Lenalidomide Plus Chemotherapy for AML

Clinical trial NCT01681537 · COMPLETED

Trial details

NCT number: NCT01681537
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myelogenous Leukemia

Start date: 2012-09-01
Primary completion: 2015-09-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.